Sfoglia per Autore
Diadenosines as FHIT-ness instructors
2006 M. Campiglio, F. Bianchi, F. Andriani, G. Sozzi, E. Tagliabue, S. Menard, L. Roz
FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells
2006 F. Bianchi, A. Magnifico, C. Olgiati, N. Zanesi, Y. Pekarsky, E. Tagliabue, C.M. Croce, S. Menard, M. Campiglio
Fhit expression protects against HER2-driven breast tumor development: Unraveling the molecular interconnections
2007 F. Bianchi, E. Tagliabue, S. Menard, M. Campiglio
Relevant role of repeated intreperitoneally treatment with CpG-ODN in mice bearing advanced-stage of human ovarian carcinomas
2009 L. Sfondrini, M. De Cesare, M. Campiglio, F. Bianchi, P. Perego, C. Rumio, E. Tagliabue, A. Balsari
Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinomas and repeatedly treated intraperitoneally with CpG-ODN
2010 M. De Cesare, L. Sfondrini, M. Campiglio, M. Sommariva, F. Bianchi, P. Perego, N. van Rooijen, R. Supino, C. Rumio, F. Zunino, G. Pratesi, E. Tagliabue, A. Balsari
Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility
2010 G.C. Ghedini, V. Ciravolo, M. Tortoreto, S. Giuffre, F. Bianchi, M. Campiglio, M. Mortarino, M. Figini, A. Coliva, M.L. Carcangiu, M. Zambetti, T. Piazza, S. Ferrini, S. Menard, E. Tagliabue, S.M. Pupa
HER2 splice variants and their relevance in breast cancer
2011 M. Sasso, F. Bianchi, V. Ciravolo, E. Tagliabue, M. Campiglio
Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy
2012 V. Ciravolo, V. Huber, G.C. Ghedini, E. Venturelli, F. Bianchi, M. Campiglio, D. Morelli, A. Villa, P. Della Mina, S. Menard, P. Filipazzi, L. Rivoltini, E. Tagliabue, S.M. Pupa
Effect of adjuvant trastuzumab treatment in conventional clinical setting : an observational retrospective multicenter Italian study
2013 M. Campiglio, R. Bufalino, M. Sasso, E. Ferri, P. Casalini, V. Adamo, A. Fabi, R. Aiello, F. Riccardi, E. Valle, V. Scotti, G. Tabaro, D. Giuffrida, E. Tarenzi, A. Bologna, G. Mustacchi, F. Bianchi, A. Balsari, S. Ménard, E. Tagliabue
Prognostic role of tumor size in T1 HER2-positive breast cancers treated with adjuvant trastuzumab
2014 M. Campiglio, M. Sandri, M. Sasso, F. Bianchi, A. Balsari, S. Ménard, E. Tagliabue
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells
2014 I. Plantamura, P. Casalini, E. Dugnani, M. Sasso, E. D'Ippolito, M. Tortoreto, M. Cacciatore, C. Guarnotta, C. Ghirelli, I. Barajon, F. Bianchi, T. Triulzi, R. Agresti, A. Balsari, M. Campiglio, C. Tripodo, M.V. Iorio, E. Tagliabue
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens
2014 A. Martinetti, R. Miceli, E. Sottotetti, M. Di Bartolomeo, F. de Braud, A. Gevorgyan, K.F. Dotti, E. Bajetta, M. Campiglio, F. Bianchi, G. Bregni, F. Pietrantonio
Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment
2015 V. Le Noci, M. Tortoreto, A. Gulino, C. Storti, F. Bianchi, N. Zaffaroni, C. Tripodo, E. Tagliabue, A. Balsari, L. Sfondrini
Fhit nuclear import following EGF stimulation sustains proliferation of breast cancer cells
2015 F. Bianchi, M. Sasso, F. Turdo, G.L. Beretta, P. Casalini, C. Ghirelli, L. Sfondrini, S. Ménard, E. Tagliabue, M. Campiglio
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
2016 F. Turdo, F. Bianchi, P. Gasparini, M. Sandri, M. Sasso, L. De Cecco, L. Forte, P. Casalini, P. Aiello, L. Sfondrini, R. Agresti, M.L. Carcangiu, I. Plantamura, G. Sozzi, E. Tagliabue, M. Campiglio
Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells
2016 F. Bianchi, M. Sommariva, L. De Cecco, T. Triulzi, S. Romero Cordoba, E. Tagliabue, L. Sfondrini, A. Balsari
Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages
2017 M. Sommariva, V. Le Noci, C. Storti, F. Bianchi, E. Tagliabue, A. Balsari, L. Sfondrini
Exploiting poly(I:C) to induce cancer cell apoptosis
2017 F. Bianchi, S. Pretto, E. Tagliabue, A. Balsari, L. Sfondrini
Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases
2018 V. Le Noci, S. Guglielmetti, S. Arioli, C. Camisaschi, F. Bianchi, M. Sommariva, C. Storti, T. Triulzi, C. Castelli, A. Balsari, E. Tagliabue, L. Sfondrini
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
2018 L. Forte, F. Turdo, C. Ghirelli, P. Aiello, P. Casalini, M. Iorio, E. D'Ippolito, P. Gasparini, R. Agresti, B. Belmonte, G. Sozzi, L. Sfondrini, E. Tagliabue, M. Campiglio, F. Bianchi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile